Enzyre

Series-A
enzyre.com Biotech & Healthcare
Total Funding $11.9M
Latest Round Undisclosed Series-A
Last Announced Jan 13, 2023
Investors Undisclosed
Decision Makers 5 Available

About Enzyre

Our technology will revolutionize blood coagulation management. The ENZYSYSTEM enables real near patient blood coagulation analysis, with the measured data being effortlessly made available to the treating physician, irrespective of his or her physical location.

Sectors & Market Categories

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-A
Global Headquarters Undisclosed
Tracked Since Nov 8, 2026

Web & Domain Identity

Official Website enzyre.com
Domain Registered Date Undisclosed

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Company Profile

Company Milestones & Timeline

2 Events
  1. Capital Raise

    Raised undisclosed · Series-A

    fundraisingfox.com

  2. Capital Raise

    Raised $11,870,000 · Series-A

    startupintros.com

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for Enzyre.

Funding History

2 Rounds
Series-A equity · Jan 13, 2023
Series-A equity · Nov 2, 2022

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

Recently funded startups
New SaaS launches
Never pay twice for contacts